# The Value of Combining Carbon Dioxide Gap and Oxygen-Derived Variables with Lactate Clearance in Predicting Mortality after Resuscitation of Septic Shock Patients

Authors: Walid Ahmed; Mohamed Laimoud
Journal: Critical Care Research and Practice
 (2021)

---

## Abstract

Background. Achieving hemodynamic stabilization does not prevent progressive tissue hypoperfusion and organ dysfunction during resuscitation of septic shock patients. Many indicators have been proposed to judge the optimization of oxygen delivery to meet tissue oxygen consumption. Methods. A prospective observational study was conducted to evaluate and validate combining CO2 gap and oxygen-derived variables with lactate clearance during early hours of resuscitation of adults presenting with septic shock. Results. Our study included 456 adults with a mean age of 63.2 ± 6.9 years, with 71.9% being males. Respiratory and urinary infections were the origin of about 75% of sepsis. Mortality occurred in 164 (35.9%) patients. The APACHE II score was 18.2 ± 3.7 versus 34.3 ± 6.8 (p<0.001), the initial SOFA score was 5.8 ± 3.1 versus 7.3 ± 1.4 (p=0.001), while the SOFA score after 48 hours was 4.2 ± 1.8 versus 9.4 ± 3.1 (p<0.001) in the survivors and nonsurvivors, respectively. Hospital mortality was independently predicted by hyperlactatemia (OR: 2.47; 95% CI: 1.63–6.82, p=0.004), PvaCO2 gap (OR: 2.62; 95% CI: 1.28–6.74, p=0.026), PvaCO2/CavO2 ratio (OR: 2.16; 95% CI: 1.49–5.74, p=0.006), and increased SOFA score after 48 hours of admission (OR: 1.86; 95% CI: 1.36–8.13, p=0.02). A blood lactate cutoff of 40 mg/dl at the 6th hour of resuscitation (T6) had a 92.7% sensitivity and 75.3% specificity for predicting hospital mortality (AUROC = 0.902) with 81.6% accuracy. Combining the lactate cutoff of 40 mg/dl and PvaCO2/CavO2 ratio cutoff of 1.4 increased the specificity to 93.2% with a sensitivity of 75.6% in predicting mortality and with 86.8% accuracy. Combining the lactate cutoff of 40 mg/dl and PvaCO2 gap of 6 mmHg increased the sensitivity to 93% and increased the specificity to 98% in predicting mortality with 91% accuracy. Conclusion. Combining the carbon dioxide gap and arteriovenous oxygen difference with lactate clearance during early hours of resuscitation of septic shock patients helps to predict hospital mortality more accurately.


---

## Body

## 1. Background

Early detection of tissue hypoperfusion and rapid, efficient resuscitation is fundamental in the successful management of patients presenting with septic shock [1]. Recent guidelines from the Surviving Sepsis Campaign for management of septic shock patients focused on hemodynamic support through a systematic protocol of fluids and vasopressor therapy. The goal was to improve tissue perfusion and meet tissue oxygen demands [2]. The guidelines recommended continuing resuscitation and restoring mean arterial pressure (MAP) ≥ 65 mmHg with lactate clearance. This was based on the understanding that lactate clearance could serve as a surrogate for the reversal of global tissue hypoxia [3, 4]. Many indicators have been proposed to determine optimization of oxygen delivery (DO2) to meet tissue oxygen consumption (VO2) [5, 6]. However, achieving hemodynamic stabilization does not prevent progressive tissue hypoperfusion and multiorgan dysfunction [7]. No consistent advantages have been found for lactate guided resuscitation over using oxygen indicators [8–10]. The venoarterial carbon dioxide difference (PvaCO2) has been proposed as an indicator of tissue hypoperfusion [11–13]. A persistently high PvaCO2 gap despite resuscitation efforts may anticipate lactate changes and adverse outcomes [14] as CO2 production does not exceed O2 availability during aerobic conditions. Thus, the ratio between the PvaCO2 and the arteriovenous oxygen content difference (CavO2) may detect patients with anaerobic metabolism. Mekontso-Dessap et al. [15] reported that a PvaCO2 to CavO2 ratio of 1.4 was superior to PvaCO2 in predicting hyperlactatemia. The goal of this prospective observational study was to evaluate predictors of outcomes by combining the CO2 gap to CavO2, PvaCO2/CavO2 ratio, and lactate clearance during early hours of resuscitation of adult patients presenting with septic shock.


## 2. Methods

### 2.1. Patient Enrollment

This study was conducted at Cairo University Hospitals between January 2018 and February 2020 after getting the approval of the ethical committee. Informed consents were obtained from the enrolled patients. All 18-year-old or older consecutive patients who presented with septic shock were enrolled in the study. Septic shock was diagnosed as sepsis with persisting hypotension and a blood lactate level >2 mmol/L (18 mg/dl) despite adequate fluid resuscitation and necessitating vasopressors to get a mean arterial blood pressure ≥65 mm Hg [2]. Sepsis was defined as critical organ dysfunction due to a dysregulated body response to infection and associated with an acute change in Sequential Organ Failure Assessment (SOFA) score ≥ 2 [2].Exclusion criteria included patients below 18 years of age, patients with chronic obstructive pulmonary disease or interstitial pulmonary diseases, refusal to consent, conditions that could affect lactate clearance such as chronic liver disease or alcoholism, diabetic patients on metformin therapy, and patients with different ventilation parameters during the 2 points of measurements.


### 2.2. Protocol of Resuscitation

All enrolled patients were resuscitated according to the Surviving Sepsis Campaign guidelines [2, 16]. Resuscitation started with crystalloids (30 ml/kg), and norepinephrine was started in the first hour as the first-choice vasopressor to maintain MAP ≥65 mm Hg. Cultures were obtained before starting broad-spectrum antibiotics. Central venous catheterization was performed via a jugular or subclavian approach, and the tip of the catheter was confirmed in the upper part of the right atrium by a chest X-ray. Arterial catheterization was performed via a radial or femoral approach, and the catheter position was confirmed by arterial waveform and blood gases analysis. Simultaneous arterial and central venous blood gases samples were obtained and analyzed.


### 2.3. Measured Variables

(i)
Oxygenation and ventilation parameters were compared at the start of resuscitation (T0) and after 6 hours of resuscitation (T6) including arterial oxygen tension (PaO2), arterial carbon dioxide tension (PaCO2), arterial oxygen saturation (SaO2%), central venous oxygen tension (PcvO2), central venous carbon dioxide tension (PcvCO2), central venous oxygen saturation (ScvO2%), the arterial oxygen content (CaO2), and central venous oxygen content (CvO2). The difference between arterial and venous oxygen content (CavO2), oxygen extraction ratio (ER O2%), CO2 gap between venous and arterial samples (PvaCO2), and PvaCO2/CavO2 ratio were calculated as follows: ER O2% = (CaO2 − CvO2)/CaO2 and PvaCO2 = PvCO2 − PaCO2 [17].(ii)
Lactate was recorded at 3 points: before (T0), after 6 hours (T6), and after 12 hours (T12) of resuscitation. Lactate clearance and delta changes were calculated from the difference between the second or the third reading and the first reading, divided by the first reading. This determined maximal change in the second or third reading.(iii)
APACHE II and SOFA scores were calculated upon admission, as well as SOFA scores after 48 hours.(iv)
Hospital mortality was the primary outcome, while the secondary outcomes included ICU stay and the need for hemodialysis.


### 2.4. Statistical Analysis

(i)
Data are reported as mean ± standard deviation (±SD), median with interquartile range (IQR), or the number of cases and relative frequencies (percentages) when appropriate. Comparison of quantitative variables between the study groups was calculated using thet-test or Mann-Whitney U test for independent samples. For categorical data, a chi-square test was performed. Correlation between various variables was done using the Pearson correlation coefficient for continuous variables. A probability value (p value) less than 0.05 was considered statistically significant. Receiver operator characteristic (ROC) analysis was used to determine the optimum cutoff values for determining mortality.(ii)
We developed the lactate-PvaCO2 score as follows: after multivariate logistic regression analysis to identify independent risk factors associated with mortality, the probability of using a stepwise analysis model was 0.05 for entry and 0.1 for removal. We tested various regression models using four variables (lactate, PvaCO2, CavO2, and PvaCO2/CavO2). We evaluated the final model (lactate-PvaCO2) for the goodness of fit using the Hosmer-Lemeshow test (p>0.05). The variables were classified in the final model into clinically meaningful categories, and the estimated risk of mortality was recorded in each category. Binary logistic regression was run to explore potential predictors (following fluid resuscitation) for mortality. A score was calculated according to the regression output as follows: mortality probability=1/1+exp−−8.968+0.119∗lactate+0.379∗PvaCO2. “exp” is an exponential value (Tables 1 and 2).(iii)
All statistical calculations were done using SPSS (Statistical Package for the Social Sciences; SPSS Inc., Chicago, IL, USA) version 26 for Microsoft Windows.


## 2.1. Patient Enrollment

This study was conducted at Cairo University Hospitals between January 2018 and February 2020 after getting the approval of the ethical committee. Informed consents were obtained from the enrolled patients. All 18-year-old or older consecutive patients who presented with septic shock were enrolled in the study. Septic shock was diagnosed as sepsis with persisting hypotension and a blood lactate level >2 mmol/L (18 mg/dl) despite adequate fluid resuscitation and necessitating vasopressors to get a mean arterial blood pressure ≥65 mm Hg [2]. Sepsis was defined as critical organ dysfunction due to a dysregulated body response to infection and associated with an acute change in Sequential Organ Failure Assessment (SOFA) score ≥ 2 [2].Exclusion criteria included patients below 18 years of age, patients with chronic obstructive pulmonary disease or interstitial pulmonary diseases, refusal to consent, conditions that could affect lactate clearance such as chronic liver disease or alcoholism, diabetic patients on metformin therapy, and patients with different ventilation parameters during the 2 points of measurements.


## 2.2. Protocol of Resuscitation

All enrolled patients were resuscitated according to the Surviving Sepsis Campaign guidelines [2, 16]. Resuscitation started with crystalloids (30 ml/kg), and norepinephrine was started in the first hour as the first-choice vasopressor to maintain MAP ≥65 mm Hg. Cultures were obtained before starting broad-spectrum antibiotics. Central venous catheterization was performed via a jugular or subclavian approach, and the tip of the catheter was confirmed in the upper part of the right atrium by a chest X-ray. Arterial catheterization was performed via a radial or femoral approach, and the catheter position was confirmed by arterial waveform and blood gases analysis. Simultaneous arterial and central venous blood gases samples were obtained and analyzed.


## 2.3. Measured Variables

(i)
Oxygenation and ventilation parameters were compared at the start of resuscitation (T0) and after 6 hours of resuscitation (T6) including arterial oxygen tension (PaO2), arterial carbon dioxide tension (PaCO2), arterial oxygen saturation (SaO2%), central venous oxygen tension (PcvO2), central venous carbon dioxide tension (PcvCO2), central venous oxygen saturation (ScvO2%), the arterial oxygen content (CaO2), and central venous oxygen content (CvO2). The difference between arterial and venous oxygen content (CavO2), oxygen extraction ratio (ER O2%), CO2 gap between venous and arterial samples (PvaCO2), and PvaCO2/CavO2 ratio were calculated as follows: ER O2% = (CaO2 − CvO2)/CaO2 and PvaCO2 = PvCO2 − PaCO2 [17].(ii)
Lactate was recorded at 3 points: before (T0), after 6 hours (T6), and after 12 hours (T12) of resuscitation. Lactate clearance and delta changes were calculated from the difference between the second or the third reading and the first reading, divided by the first reading. This determined maximal change in the second or third reading.(iii)
APACHE II and SOFA scores were calculated upon admission, as well as SOFA scores after 48 hours.(iv)
Hospital mortality was the primary outcome, while the secondary outcomes included ICU stay and the need for hemodialysis.


## 2.4. Statistical Analysis

(i)
Data are reported as mean ± standard deviation (±SD), median with interquartile range (IQR), or the number of cases and relative frequencies (percentages) when appropriate. Comparison of quantitative variables between the study groups was calculated using thet-test or Mann-Whitney U test for independent samples. For categorical data, a chi-square test was performed. Correlation between various variables was done using the Pearson correlation coefficient for continuous variables. A probability value (p value) less than 0.05 was considered statistically significant. Receiver operator characteristic (ROC) analysis was used to determine the optimum cutoff values for determining mortality.(ii)
We developed the lactate-PvaCO2 score as follows: after multivariate logistic regression analysis to identify independent risk factors associated with mortality, the probability of using a stepwise analysis model was 0.05 for entry and 0.1 for removal. We tested various regression models using four variables (lactate, PvaCO2, CavO2, and PvaCO2/CavO2). We evaluated the final model (lactate-PvaCO2) for the goodness of fit using the Hosmer-Lemeshow test (p>0.05). The variables were classified in the final model into clinically meaningful categories, and the estimated risk of mortality was recorded in each category. Binary logistic regression was run to explore potential predictors (following fluid resuscitation) for mortality. A score was calculated according to the regression output as follows: mortality probability=1/1+exp−−8.968+0.119∗lactate+0.379∗PvaCO2. “exp” is an exponential value (Tables 1 and 2).(iii)
All statistical calculations were done using SPSS (Statistical Package for the Social Sciences; SPSS Inc., Chicago, IL, USA) version 26 for Microsoft Windows.


## 3. Results

### 3.1. Baseline and Clinical Characteristics of the Studied Patients

A total of 456 adult patients were included in the study with a mean age of 63.2 ± 6.9 years, with 71.9% being males. Respiratory and urinary infections were 75% of sepsis etiology. The nonsurvivors were significantly older (65.8 ± 7.2 versus 61.4 ± 4.6,p=0.001) with more frequent rates of chronic kidney disease (61.6% versus 40.1%, p=0.02) and less frequent rates of diabetes mellitus (60.4% versus 64.4%, p=0.04) compared to the survivors. Mortality occurred in 164 (35.9%) patients. The APACHE II score was 18.2 ± 3.7 versus 34.3 ± 6.8 (p<0.001) and the initial SOFA score was 5.8 ± 3.1 versus 7.3 ± 1.4 (p=0.001), while SOFA score after 48 hours was 4.2 ± 1.8 versus 9.4 ± 3.1 (p<0.001) in the survivors and nonsurvivors, respectively. The nonsurvivors had significant hypoalbuminemia (3.2 ± 1.6 versus 3.6 ± 1.3, p=0.02) and a higher mean serum creatinine level (1.6 ± 0.6 versus 1.2 ± 0.2, p=0.04) compared to the survivors. The survivors had a significantly longer length of ICU stay (6.8 ± 2.1 versus 3.6 ± 1.7, p<0.001) but a lesser need for hemodialysis (10.3% versus 23.2%, p=0.02) compared to the nonsurvivors (Table 3).Table 1
Lactate-PvaCO2 model for estimated risk of mortality with point scoring according to its individual subscores.
VariablesRangePoint scoreLactate1617123131841924625308313610374211434813495415556016616618677220737822798423859025919627971022810310830109114321151203412112635127132371331383913914440PvaCO21637129131814192420Table 2
Estimated risk of mortality according to the summed point scores.
Summed point scoreEstimated mortality (%)10.020.030.040.150.160.270.280.490.5100.8111.2121.9132.8144.2156.2169.11713.21818.81926.02034.82144.72255.12365.02473.82581.02686.62790.82893.72995.83097.23198.13298.73399.23499.53599.63699.83799.83899.93999.940 or above100.0Table 3
Baseline characteristics of the study population.
The studied variablesAll patients (N = 456)Survivors (N = 292)Nonsurvivors (N = 164)p valueAge (years)63.2 ± 6.961.4 ± 4.665.8 ± 7.20.001Gender (male)328 (71.9%)216 (73.9%)112 (68.3%)0.34Diabetes mellitus,n (%)287 (62.9)188 (64.4)99 (60.4)0.04Chronic kidney disease,n (%)218 (47.8)117 (40.1)101 (61.6)0.02Chronic heart failure,n (%)127 (28)83 (28.4)44 (26.8)0.34Coronary artery disease,n (%)141 (30.9)89 (30.4)52 (31.7)0.42Previous cerebrovascular stroke,n (%)26 (5.7)18 (6.2)8 (4.9)0.7Left ventricle EF (%)52.3 ± 6.851.6 ± 8.749.4 ± 4.80.31Source of sepsis,n (%)Pneumonia227 (49.8)154 (52.7)73 (44.5)0.38Urinary113 (24.8)64 (21.9)49 (29.8)Abdominal82 (17.9)59 (20.2)23 (14.1)Soft tissue34 (7.5)21 (7.2)13 (9.7)APACHE II score24.3 ± 9.718.2 ± 3.734.3 ± 6.8<0.001SOFA score at admission6.4 ± 1.65.8 ± 3.17.3 ± 1.40.001SOFA score after 48 hours6.2 ± 3.64.2 ± 1.89.4 ± 3.1<0.001Need for dialysis68 (14.9%)30 (10.3%)38 (23.2%)0.02Length of stay (days)5.6 ± 2.46.8 ± 2.13.6 ± 1.7<0.001Hemoglobin (g/dL)10.6 ± 2.310.9 ± 1.29.82 ± 2.30.51Platelet count (×103/ml)134.2 ± 52.6146.7 ± 38.3128.6 ± 52.70.2INR1.3 ± 0.711.2 ± 0.621.1 ± 0.450.61Creatinine (mg/dL)1.4 ± 0.31.2 ± 0.21.6 ± 0.60.041Bilirubin (mg/dL)2.1 ± 1.21.8 ± 1.32.4 ± 1.60.13Albumin (mg/dL)3.6 ± 1.43.6 ± 1.33.2 ± 1.60.02AST(U/L)21.4 ± 2.620.9 ± 2.826.3 ± 3.40.015ALT(U/L26.8 ± 3.124.4 ± 2.727.4 ± 3.40.22APACHE II: Acute Physiology and Chronic Health Evaluation II; SOFA: Sequential Organ Failure Assessment; INR: international normalized ratio; ALT: alanine transaminase; AST: aspartate transferase. Data are presented as mean (±SD) orN (%).


### 3.2. The Studied Hemodynamic Variables

The mean arterial blood pressure (MAP), heart rate, and temperature measurements were similar in both groups. Before starting resuscitation, the nonsurvivors had a significantly lower mean ScvO2% (52.6 ± 8.8 versus 61.4 ± 10.3, p=0.003) and PvaCO2/CavO2 ratio (1.8 ± 0.15 versus 2.2 ± 0.81, p=0.013) with a higher oxygen extraction ratio (40 ± 7.3% versus 35 ± 8.1%, p=0.002) compared to the survivors. However, there were no significant differences between both groups in blood lactate levels, arterial PO2, arterial oxygen content, arterial PCO2, or carbon dioxide gap (PvaCO2) at the initiation of resuscitation (Table 4 and Figure 1).Table 4
Hemodynamic and blood gases’ variables of the studied patients.
The studied variablesAll patientsSurvivorsNonsurvivorsp valueInitial values (T0)MAP (mmHg)42.3 ± 5.443.6 ± 6.741.4 ± 3.10.43Heart rate (beats/min)106 ± 26.3102 ± 38.3114 ± 29.70.19Temperature (°C)37.2 ± 1.737.1 ± 1.937 ± 1.870.32Norepinephrine (μg/kg/minute)0.41 ± 0.280.36 ± 0.210.67 ± 0.08<0.001Blood lactate (mg/dl)53.8 ± 18.951.4 ± 15.257.8 ± 18.70.12PaO2 (mmHg)61.4 ± 24.462.6 ± 12.360.2 ± 26.40.74CaO2 (ml/dL)12.6 ± 1.312.1 ± 1.811.8 ± 1.70.25CvO2 (ml/dL)7.6 ± 1.78.2 ± 1.47.1 ± 1.30.003CavO2 (ml/dL)4.3 ± 1.34.4 ± 1.64.9 ± 1.10.023ScvO2 (%)57.6 ± 9.661.4 ± 10.352.6 ± 8.80.003ER O2 (%)36 ± 8.2%35 ± 8.1%40 ± 7.3%0.002PaCO2 (mmHg)46.3 ± 8.637.4 ± 7.638.4 ± 8.70.571PvCO2 (mmHg)38.4 ± 7.446.3 ± 8.446.4 ± 10.20.81PvaCO2 (mmHg)9.1 ± 3.29.2 ± 3.48.3 ± 2.80.32PvaCO2/CavO22.1 ± 0.722.2 ± 0.811.8 ± 0.150.013Follow-up values (T6)MAP (mmHg)62.7 ± 12.469.8 ± 5.460.6 ± 4.8<0.001Norepinephrine (μg/kg/minute)0.82 ± 0.380.28 ± 0.231.02 ± 0.11<0.001Dopamine (μg/kg/minute)5.63 (3.32–13.4)4.6 (3.1–9.41)6.34 (5.47–13.42)0.06Fluid intake (liters)3.84 (2.62–6.24)2.73 (2.42–4.35)3.26 (2.94–6.31)0.03Lactate T6 (mg/dl)49.4 ± 24.736.3 ± 14.473.4 ± 30.4<0.001PaO2 (mmHg)84.2 ± 38.489.7 ± 31.271.7 ± 29.40.044CaO2 (ml/dL)13.7 ± 1.813.9 ± 1.412.7 ± 1.610.42CvO2 (ml/dL)8.3 ± 1.68.2 ± 1.78.7 ± 1.50.103CavO2 (ml/dL)4.6 ± 1.44.9 ± 1.44.1 ± 1.30.004ScvO2 (%)65.8 ± 9.771.3 ± 11.264.4 ± 8.40.038ER O2 (%)36.4 ± 8.9%37 ± 9.4%32.7 ± 9.5%0.004PaCO2 (mmHg)41.7 ± 5.835.6 ± 4.336.6 ± 7.30.42PvCO2 (mmHg)36.2 ± 6.240.5 ± 4.345.3 ± 6.120.002PvaCO2 (mmHg)6.2 ± 4.64.7 ± 3.628.3 ± 4.7<0.001PvaCO2/CavO21.4 ± 1.11.2 ± 0.722.1 ± 1.13<0.001Lactate T12 (mg/dl)37.8 ± 13.221.6 ± 8.757.6 ± 16.3<0.001MAP: mean arterial pressure; PaO2: arterial oxygen tension; CaO2: arterial oxygen content; CvO2: central venous oxygen content; CavO2: arteriovenous oxygen content difference; ScvO2%: central venous oxygen saturation; ER O2: oxygen extraction ratio; PaCO2: arterial carbon dioxide tension; PvCO2: venous carbon dioxide tension; PvaCO2: CO2 gap.Figure 1
Oxygen extraction and blood lactate trends in the survivors and nonsurvivors.After 6 hours of resuscitation, the survivors showed a significantly higher MAP (69.8 ± 5.4 versus 60.6 ± 4.8,p<0.001), a lower mean blood lactate level (36.3 ± 14.4 versus 73.4 ± 30.4, p<0.001), a higher arteriovenous oxygen content difference (4.9 ± 1.4 versus 4.1 ± 1.3, p=0.004), a lower carbon dioxide gap (4.7 ± 3.62 versus 8.3 ± 4.7, p<0.001), a lower PvaCO2/CavO2 ratio (1.2 ± 0.72 versus 2.1 ± 1.13, p<0.001), a higher ScvO2% (71.3 ± 11.2 versus 64.4 ± 8.4, p=0.038), and lesser doses of norepinephrine drip (0.28 ± 0.23 versus 1.02 ± 0.11, p<0.001) compared to the nonsurvivors. After 12 hours of resuscitation, the mean blood lactate level was 21.6 ± 8.7 versus 57.6 ± 16.3 (p<0.001 ) in the survivors and nonsurvivors, respectively (Table 4 and Figures 1 and 2).Figure 2
The SOFA score, CO2 gap, and oxygen content difference between the survivors and nonsurvivors.Paired comparisons showed a declining SOFA score in the survivors and increasing trend in the nonsurvivors (−2.0 [−1.9 to −1.4] versus 3 [2.1–3.1],p<0.001), respectively. Lactate clearance was evident in the survivors, while lactate level elevation occurred in the nonsurvivors. The delta lactate change was −29.4% [−35% to −26%] versus 26.9% [24%–41%] (p<0.001) in the survivors and nonsurvivors, respectively. ∆CavO2 was 14% [12%–27%] versus −21% [−20% to −8%] (p<0.001) and ∆PvaCO2 was −57% [−49 to −26%] versus −8% [−12% to 23%] (p<0.001), while the ∆PvaCO2/CavO2 ratio was −71% [−54% to −28%] versus 7% [4%–51%] (p<0.001) in the survivors and nonsurvivors, respectively (Table 5).Table 5
Changes of the studied variables with resuscitation.
The studied variablesSurvivorsNonsurvivorspSOFA score change−2.0 (−1.9 to −1.4)3 (2.1–3.1)<0.001Norepinephrine dose change−0.06 (−01 to 0.2)0.1 (0.01–0.11)<0.001∆lactate (%)−29.4 (−35 to −26)26.9 (24–41)<0.001ΔCavO2 (%)14 (12% −27)−21 (−20 to −8)<0.001ΔPvaCO2 (%)−57 (−49 to −26)−8 (−12 to 23)<0.001ΔPvaCO2/CavO2 (%)−71 (−54 to −28)7 (4–51)<0.001Data are presented as median and interquartile range (IQR). SOFA change = SOFA at 48 hours − admission SOFA. Norepinephrine dose change = dose at T6 − dose at T0. Lactate, CavO2, PvaCO2, PvaCO2/CavO2% change = T6 − T0/T0.Norepinephrine dosage changes were positively correlated with delta changes of PvaCO2 and lactate and PvaCO2/CavO2 (r: 0.304, 0.728, and 0.386 and p<0.001,0.001&<0.001, respectively). Arteriovenous oxygen content delta changes were negatively correlated with delta changes of PvaCO2, lactate, and PvaCO2/CavO2 (r: −0.322, −0.436, and −0.4 respectively; p<0.001 for all). Multivariate regression analysis showed that the delta change in oxygen (A-V) content was the only significant predictor of delta change in lactate, that is, lactate clearance (−0.478, CI 95%: −0.232 to −0.828, p = 0.001) in a model that included delta changes in PvaCO2, CavO2, and PvaCO2/CavO2.


### 3.3. The Predictors of Hospital Mortality

In a multivariate regression analysis, hospital mortality was independently predicted by hyperlactatemia (OR: 2.47; 95% CI: 1.63–6.82,p=0.004), PvaCO2 gap (OR: 2.62; 95% CI: 1.28–6.74, p=0.026), PvaCO2/CavO2 ratio (OR: 2.16; 95% CI: 1.49–5.74, p=0.006), and increased SOFA score after 48 hours (OR: 1.86; 95% CI: 1.36–8.13, p=0.02) (Table 6).Table 6
Multivariate regression analysis for predicting in-hospital mortality.
The studied variablesOdds ratio95% CIp valueAPACHE II1.280.87–1.340.31Delta SOFA after 48 hours1.861.36–8.130.02Lactate2.471.63–6.820.004PvaCO2/CavO22.161.49–5.740.006PvaCO22.621.28–6.740.026The ROC analysis for cutoffs for the prediction of hospital mortality is summarized in Table5. Blood lactate cutoff of 40 mg/dl at T6 had a 92.7% sensitivity and 75.3% specificity for predicting hospital mortality (AUROC = 0.902) with 67.9% PPV, 94.8% NPV, and 81.6% accuracy. A PvaCO2 cutoff of 6 mmHg at T6 had a 71% sensitivity and 77% specificity for predicting hospital mortality (AUROC = 0.791) with 63% PPV, 82%NPV, and 75% accuracy. PvaCO2/CavO2 cutoff of 1.4 at T6 had a 76% sensitivity and 70% specificity for predicting hospital mortality (AUROC = 0.793) with 58% PPV, 84% NPV, and 72% accuracy. Combining cutoffs for lactate (40 mg/dl) and PvaCO2/CavO2 ratio (1.4) increased the specificity to 93.2%, with a sensitivity of 75.6% in predicting mortality and 86.8% accuracy. Combining cutoffs for lactate (40 mg/dl) and PvaCO2 gap (6 mmHg) increased the sensitivity to 93% and increased the specificity to 98% in predicting mortality with 91% accuracy (Table 7 and Figures 3 and 4).Figure 3
ROC analysis to determine possible cutoffs (after resuscitation) to predict in-hospital mortality. The blue line represents PvaCO2/CavO2. The green line represents PvaCO2. The red line represents lactate.Table 7
ROC analysis of studied variables in predicting mortality.
ROC analysisLactatePvaCO2PvaCO2/CavO2Combined lactate-PvaCO2Cutoff4061.420.5Area under the curve0.9020.7910.7930.930Sensitivity92.7%71%76%93%Specificity75.3%77%70%98%PPV67.9%63%58%84%NPP94.8%82%84%96%Accuracy81.6%75%72%91%LR+3.83.02.59.7LR−0.10.40.30.1ROC: receiver operating characteristics; PPV: positive predictive value; NPP: negative predictive value; LR: likelihood ratio.Figure 4
ROC analysis to determine possible cutoffs (after resuscitation) to predict in-hospital mortality. The blue line represents combined lactate and PvaCO2 curve. The green line represents lactate. The grey line represents PvaCO2.


## 3.1. Baseline and Clinical Characteristics of the Studied Patients

A total of 456 adult patients were included in the study with a mean age of 63.2 ± 6.9 years, with 71.9% being males. Respiratory and urinary infections were 75% of sepsis etiology. The nonsurvivors were significantly older (65.8 ± 7.2 versus 61.4 ± 4.6,p=0.001) with more frequent rates of chronic kidney disease (61.6% versus 40.1%, p=0.02) and less frequent rates of diabetes mellitus (60.4% versus 64.4%, p=0.04) compared to the survivors. Mortality occurred in 164 (35.9%) patients. The APACHE II score was 18.2 ± 3.7 versus 34.3 ± 6.8 (p<0.001) and the initial SOFA score was 5.8 ± 3.1 versus 7.3 ± 1.4 (p=0.001), while SOFA score after 48 hours was 4.2 ± 1.8 versus 9.4 ± 3.1 (p<0.001) in the survivors and nonsurvivors, respectively. The nonsurvivors had significant hypoalbuminemia (3.2 ± 1.6 versus 3.6 ± 1.3, p=0.02) and a higher mean serum creatinine level (1.6 ± 0.6 versus 1.2 ± 0.2, p=0.04) compared to the survivors. The survivors had a significantly longer length of ICU stay (6.8 ± 2.1 versus 3.6 ± 1.7, p<0.001) but a lesser need for hemodialysis (10.3% versus 23.2%, p=0.02) compared to the nonsurvivors (Table 3).Table 1
Lactate-PvaCO2 model for estimated risk of mortality with point scoring according to its individual subscores.
VariablesRangePoint scoreLactate1617123131841924625308313610374211434813495415556016616618677220737822798423859025919627971022810310830109114321151203412112635127132371331383913914440PvaCO21637129131814192420Table 2
Estimated risk of mortality according to the summed point scores.
Summed point scoreEstimated mortality (%)10.020.030.040.150.160.270.280.490.5100.8111.2121.9132.8144.2156.2169.11713.21818.81926.02034.82144.72255.12365.02473.82581.02686.62790.82893.72995.83097.23198.13298.73399.23499.53599.63699.83799.83899.93999.940 or above100.0Table 3
Baseline characteristics of the study population.
The studied variablesAll patients (N = 456)Survivors (N = 292)Nonsurvivors (N = 164)p valueAge (years)63.2 ± 6.961.4 ± 4.665.8 ± 7.20.001Gender (male)328 (71.9%)216 (73.9%)112 (68.3%)0.34Diabetes mellitus,n (%)287 (62.9)188 (64.4)99 (60.4)0.04Chronic kidney disease,n (%)218 (47.8)117 (40.1)101 (61.6)0.02Chronic heart failure,n (%)127 (28)83 (28.4)44 (26.8)0.34Coronary artery disease,n (%)141 (30.9)89 (30.4)52 (31.7)0.42Previous cerebrovascular stroke,n (%)26 (5.7)18 (6.2)8 (4.9)0.7Left ventricle EF (%)52.3 ± 6.851.6 ± 8.749.4 ± 4.80.31Source of sepsis,n (%)Pneumonia227 (49.8)154 (52.7)73 (44.5)0.38Urinary113 (24.8)64 (21.9)49 (29.8)Abdominal82 (17.9)59 (20.2)23 (14.1)Soft tissue34 (7.5)21 (7.2)13 (9.7)APACHE II score24.3 ± 9.718.2 ± 3.734.3 ± 6.8<0.001SOFA score at admission6.4 ± 1.65.8 ± 3.17.3 ± 1.40.001SOFA score after 48 hours6.2 ± 3.64.2 ± 1.89.4 ± 3.1<0.001Need for dialysis68 (14.9%)30 (10.3%)38 (23.2%)0.02Length of stay (days)5.6 ± 2.46.8 ± 2.13.6 ± 1.7<0.001Hemoglobin (g/dL)10.6 ± 2.310.9 ± 1.29.82 ± 2.30.51Platelet count (×103/ml)134.2 ± 52.6146.7 ± 38.3128.6 ± 52.70.2INR1.3 ± 0.711.2 ± 0.621.1 ± 0.450.61Creatinine (mg/dL)1.4 ± 0.31.2 ± 0.21.6 ± 0.60.041Bilirubin (mg/dL)2.1 ± 1.21.8 ± 1.32.4 ± 1.60.13Albumin (mg/dL)3.6 ± 1.43.6 ± 1.33.2 ± 1.60.02AST(U/L)21.4 ± 2.620.9 ± 2.826.3 ± 3.40.015ALT(U/L26.8 ± 3.124.4 ± 2.727.4 ± 3.40.22APACHE II: Acute Physiology and Chronic Health Evaluation II; SOFA: Sequential Organ Failure Assessment; INR: international normalized ratio; ALT: alanine transaminase; AST: aspartate transferase. Data are presented as mean (±SD) orN (%).


## 3.2. The Studied Hemodynamic Variables

The mean arterial blood pressure (MAP), heart rate, and temperature measurements were similar in both groups. Before starting resuscitation, the nonsurvivors had a significantly lower mean ScvO2% (52.6 ± 8.8 versus 61.4 ± 10.3, p=0.003) and PvaCO2/CavO2 ratio (1.8 ± 0.15 versus 2.2 ± 0.81, p=0.013) with a higher oxygen extraction ratio (40 ± 7.3% versus 35 ± 8.1%, p=0.002) compared to the survivors. However, there were no significant differences between both groups in blood lactate levels, arterial PO2, arterial oxygen content, arterial PCO2, or carbon dioxide gap (PvaCO2) at the initiation of resuscitation (Table 4 and Figure 1).Table 4
Hemodynamic and blood gases’ variables of the studied patients.
The studied variablesAll patientsSurvivorsNonsurvivorsp valueInitial values (T0)MAP (mmHg)42.3 ± 5.443.6 ± 6.741.4 ± 3.10.43Heart rate (beats/min)106 ± 26.3102 ± 38.3114 ± 29.70.19Temperature (°C)37.2 ± 1.737.1 ± 1.937 ± 1.870.32Norepinephrine (μg/kg/minute)0.41 ± 0.280.36 ± 0.210.67 ± 0.08<0.001Blood lactate (mg/dl)53.8 ± 18.951.4 ± 15.257.8 ± 18.70.12PaO2 (mmHg)61.4 ± 24.462.6 ± 12.360.2 ± 26.40.74CaO2 (ml/dL)12.6 ± 1.312.1 ± 1.811.8 ± 1.70.25CvO2 (ml/dL)7.6 ± 1.78.2 ± 1.47.1 ± 1.30.003CavO2 (ml/dL)4.3 ± 1.34.4 ± 1.64.9 ± 1.10.023ScvO2 (%)57.6 ± 9.661.4 ± 10.352.6 ± 8.80.003ER O2 (%)36 ± 8.2%35 ± 8.1%40 ± 7.3%0.002PaCO2 (mmHg)46.3 ± 8.637.4 ± 7.638.4 ± 8.70.571PvCO2 (mmHg)38.4 ± 7.446.3 ± 8.446.4 ± 10.20.81PvaCO2 (mmHg)9.1 ± 3.29.2 ± 3.48.3 ± 2.80.32PvaCO2/CavO22.1 ± 0.722.2 ± 0.811.8 ± 0.150.013Follow-up values (T6)MAP (mmHg)62.7 ± 12.469.8 ± 5.460.6 ± 4.8<0.001Norepinephrine (μg/kg/minute)0.82 ± 0.380.28 ± 0.231.02 ± 0.11<0.001Dopamine (μg/kg/minute)5.63 (3.32–13.4)4.6 (3.1–9.41)6.34 (5.47–13.42)0.06Fluid intake (liters)3.84 (2.62–6.24)2.73 (2.42–4.35)3.26 (2.94–6.31)0.03Lactate T6 (mg/dl)49.4 ± 24.736.3 ± 14.473.4 ± 30.4<0.001PaO2 (mmHg)84.2 ± 38.489.7 ± 31.271.7 ± 29.40.044CaO2 (ml/dL)13.7 ± 1.813.9 ± 1.412.7 ± 1.610.42CvO2 (ml/dL)8.3 ± 1.68.2 ± 1.78.7 ± 1.50.103CavO2 (ml/dL)4.6 ± 1.44.9 ± 1.44.1 ± 1.30.004ScvO2 (%)65.8 ± 9.771.3 ± 11.264.4 ± 8.40.038ER O2 (%)36.4 ± 8.9%37 ± 9.4%32.7 ± 9.5%0.004PaCO2 (mmHg)41.7 ± 5.835.6 ± 4.336.6 ± 7.30.42PvCO2 (mmHg)36.2 ± 6.240.5 ± 4.345.3 ± 6.120.002PvaCO2 (mmHg)6.2 ± 4.64.7 ± 3.628.3 ± 4.7<0.001PvaCO2/CavO21.4 ± 1.11.2 ± 0.722.1 ± 1.13<0.001Lactate T12 (mg/dl)37.8 ± 13.221.6 ± 8.757.6 ± 16.3<0.001MAP: mean arterial pressure; PaO2: arterial oxygen tension; CaO2: arterial oxygen content; CvO2: central venous oxygen content; CavO2: arteriovenous oxygen content difference; ScvO2%: central venous oxygen saturation; ER O2: oxygen extraction ratio; PaCO2: arterial carbon dioxide tension; PvCO2: venous carbon dioxide tension; PvaCO2: CO2 gap.Figure 1
Oxygen extraction and blood lactate trends in the survivors and nonsurvivors.After 6 hours of resuscitation, the survivors showed a significantly higher MAP (69.8 ± 5.4 versus 60.6 ± 4.8,p<0.001), a lower mean blood lactate level (36.3 ± 14.4 versus 73.4 ± 30.4, p<0.001), a higher arteriovenous oxygen content difference (4.9 ± 1.4 versus 4.1 ± 1.3, p=0.004), a lower carbon dioxide gap (4.7 ± 3.62 versus 8.3 ± 4.7, p<0.001), a lower PvaCO2/CavO2 ratio (1.2 ± 0.72 versus 2.1 ± 1.13, p<0.001), a higher ScvO2% (71.3 ± 11.2 versus 64.4 ± 8.4, p=0.038), and lesser doses of norepinephrine drip (0.28 ± 0.23 versus 1.02 ± 0.11, p<0.001) compared to the nonsurvivors. After 12 hours of resuscitation, the mean blood lactate level was 21.6 ± 8.7 versus 57.6 ± 16.3 (p<0.001 ) in the survivors and nonsurvivors, respectively (Table 4 and Figures 1 and 2).Figure 2
The SOFA score, CO2 gap, and oxygen content difference between the survivors and nonsurvivors.Paired comparisons showed a declining SOFA score in the survivors and increasing trend in the nonsurvivors (−2.0 [−1.9 to −1.4] versus 3 [2.1–3.1],p<0.001), respectively. Lactate clearance was evident in the survivors, while lactate level elevation occurred in the nonsurvivors. The delta lactate change was −29.4% [−35% to −26%] versus 26.9% [24%–41%] (p<0.001) in the survivors and nonsurvivors, respectively. ∆CavO2 was 14% [12%–27%] versus −21% [−20% to −8%] (p<0.001) and ∆PvaCO2 was −57% [−49 to −26%] versus −8% [−12% to 23%] (p<0.001), while the ∆PvaCO2/CavO2 ratio was −71% [−54% to −28%] versus 7% [4%–51%] (p<0.001) in the survivors and nonsurvivors, respectively (Table 5).Table 5
Changes of the studied variables with resuscitation.
The studied variablesSurvivorsNonsurvivorspSOFA score change−2.0 (−1.9 to −1.4)3 (2.1–3.1)<0.001Norepinephrine dose change−0.06 (−01 to 0.2)0.1 (0.01–0.11)<0.001∆lactate (%)−29.4 (−35 to −26)26.9 (24–41)<0.001ΔCavO2 (%)14 (12% −27)−21 (−20 to −8)<0.001ΔPvaCO2 (%)−57 (−49 to −26)−8 (−12 to 23)<0.001ΔPvaCO2/CavO2 (%)−71 (−54 to −28)7 (4–51)<0.001Data are presented as median and interquartile range (IQR). SOFA change = SOFA at 48 hours − admission SOFA. Norepinephrine dose change = dose at T6 − dose at T0. Lactate, CavO2, PvaCO2, PvaCO2/CavO2% change = T6 − T0/T0.Norepinephrine dosage changes were positively correlated with delta changes of PvaCO2 and lactate and PvaCO2/CavO2 (r: 0.304, 0.728, and 0.386 and p<0.001,0.001&<0.001, respectively). Arteriovenous oxygen content delta changes were negatively correlated with delta changes of PvaCO2, lactate, and PvaCO2/CavO2 (r: −0.322, −0.436, and −0.4 respectively; p<0.001 for all). Multivariate regression analysis showed that the delta change in oxygen (A-V) content was the only significant predictor of delta change in lactate, that is, lactate clearance (−0.478, CI 95%: −0.232 to −0.828, p = 0.001) in a model that included delta changes in PvaCO2, CavO2, and PvaCO2/CavO2.


## 3.3. The Predictors of Hospital Mortality

In a multivariate regression analysis, hospital mortality was independently predicted by hyperlactatemia (OR: 2.47; 95% CI: 1.63–6.82,p=0.004), PvaCO2 gap (OR: 2.62; 95% CI: 1.28–6.74, p=0.026), PvaCO2/CavO2 ratio (OR: 2.16; 95% CI: 1.49–5.74, p=0.006), and increased SOFA score after 48 hours (OR: 1.86; 95% CI: 1.36–8.13, p=0.02) (Table 6).Table 6
Multivariate regression analysis for predicting in-hospital mortality.
The studied variablesOdds ratio95% CIp valueAPACHE II1.280.87–1.340.31Delta SOFA after 48 hours1.861.36–8.130.02Lactate2.471.63–6.820.004PvaCO2/CavO22.161.49–5.740.006PvaCO22.621.28–6.740.026The ROC analysis for cutoffs for the prediction of hospital mortality is summarized in Table5. Blood lactate cutoff of 40 mg/dl at T6 had a 92.7% sensitivity and 75.3% specificity for predicting hospital mortality (AUROC = 0.902) with 67.9% PPV, 94.8% NPV, and 81.6% accuracy. A PvaCO2 cutoff of 6 mmHg at T6 had a 71% sensitivity and 77% specificity for predicting hospital mortality (AUROC = 0.791) with 63% PPV, 82%NPV, and 75% accuracy. PvaCO2/CavO2 cutoff of 1.4 at T6 had a 76% sensitivity and 70% specificity for predicting hospital mortality (AUROC = 0.793) with 58% PPV, 84% NPV, and 72% accuracy. Combining cutoffs for lactate (40 mg/dl) and PvaCO2/CavO2 ratio (1.4) increased the specificity to 93.2%, with a sensitivity of 75.6% in predicting mortality and 86.8% accuracy. Combining cutoffs for lactate (40 mg/dl) and PvaCO2 gap (6 mmHg) increased the sensitivity to 93% and increased the specificity to 98% in predicting mortality with 91% accuracy (Table 7 and Figures 3 and 4).Figure 3
ROC analysis to determine possible cutoffs (after resuscitation) to predict in-hospital mortality. The blue line represents PvaCO2/CavO2. The green line represents PvaCO2. The red line represents lactate.Table 7
ROC analysis of studied variables in predicting mortality.
ROC analysisLactatePvaCO2PvaCO2/CavO2Combined lactate-PvaCO2Cutoff4061.420.5Area under the curve0.9020.7910.7930.930Sensitivity92.7%71%76%93%Specificity75.3%77%70%98%PPV67.9%63%58%84%NPP94.8%82%84%96%Accuracy81.6%75%72%91%LR+3.83.02.59.7LR−0.10.40.30.1ROC: receiver operating characteristics; PPV: positive predictive value; NPP: negative predictive value; LR: likelihood ratio.Figure 4
ROC analysis to determine possible cutoffs (after resuscitation) to predict in-hospital mortality. The blue line represents combined lactate and PvaCO2 curve. The green line represents lactate. The grey line represents PvaCO2.


## 4. Discussion

Our study’s main results are that septic shock patients who do not survive have worsening lactate levels with increased PvaCO2 and PvaCO2/CavO2 ratio, even after resuscitation. Mortality is predicted by hyperlactatemia, increasing PvaCO2 gap, incrementing PvaCO2/CavO2 ratio, and high SOFA score after 48 hours. Combining the PvaCO2 gap and PvaCO2/CavO2 ratio with lactate measurements can help in resuscitation and mortality prediction of septic shock patients. Many parameters are measured during septic shock resuscitation, including arterial and central venous pressures, urine output, cardiac output, blood lactate level, and central venous oxygen saturation (ScvO2%). The goal of a MAP at least 65 mmHg by the guidelines of Surviving Sepsis Campaign (SSC) has been challenged by many studies because targeting a predefined MAP by fluids and vasopressors did not lead to increased survival [18–20]. Hernandez et al. [21] reported that sepsis-induced hypotension without hyperlactatemia was associated with low mortality and less risks of organ dysfunction. Houwink et al. [22] reported the greater importance of first 24 hours’ lactate over the MAP during septic shock resuscitation. They divided patients into 4 subgroups according to blood lactate cutoff of 2 mmol/L and MAP cutoff of 65 mmHg and reported lower mortality in the groups with low blood lactate regardless of MAP [22].Our study showed significantly higher oxygen extraction and lower ScvO2% in the nonsurvivors compared to the survivors during early resuscitation without significant differences in arterial oxygen content (CaO2), arterial oxygen pressure (PaO2), or hemoglobin level in both groups. This could explain the increasing oxygen demands and failure of the aerobic metabolism with a subsequent anaerobic pathway activation and hyperlactatemia. After 6 hours of resuscitation, oxygen extraction increased and was associated with lactate clearance and improving markers of anaerobic metabolism in the survivors compared to the nonsurvivors.ScvO2% was widely recommended targeting ≥70% during the first 6 hours of septic shock resuscitation [23–26] and ScvO2% less than 70% was predictive of mortality [23, 27, 28]. However, ScvO2% was unable to differentiate survivors from nonsurvivors in other studies [29–31].Our study showed that both the survivors and nonsurvivors had similar initial lactate levels, but, after resuscitation, lactate clearance was evident in the survivors. Progressive hyperlactatemia has been associated with mortality and other negative clinical outcomes in septic and nonseptic critically ill patients [3, 4, 10, 29, 32–34]. Despite the proven beneficial role of lactate clearance in guiding resuscitation, bedside physicians have a challenge when faced with stable hemodynamics but high lactate levels as this reflects persistence of tissue hypoperfusion or slow time to clearance. High blood lactate levels may result in unnecessary fluids given that this may result in worse outcomes [35–37]. We report that the nonsurvivors received more fluids during the first 6 hours of resuscitation compared to the survivors. Boyd et al. [35] reported that more fluids transfused during the first 12 hours of septic shock resuscitation were linked to morbidity and mortality. Sadaka et al. [36] linked more fluid balance at 24 hours after resuscitation to increased mortality and documented increased mortality from 42 to 58% if there were more than 6 liters of positive fluid balance.The PvaCO2 gap has been used as an important marker of tissue perfusion and cardiac output [11–14, 38, 39]. Its value persists in septic shock resuscitation, especially after getting MAP to at least 65 mmHg and normalization of ScvO2% [11, 12, 14]. Our results showed a significant decrease of the PvaCO2 gap in the survivors after 6 hours of resuscitation compared to the nonsurvivors without a significant difference between their initial values at T0. PvaCO2 gap was also a predictor of mortality in the multivariate regression analysis. Moreover, ROC analysis showed the PvaCO2 gap cutoff of 6 mmHg had an AUROC of 0.79 but a lesser predictive value compared to blood lactate in predicting mortality. Combining lactate with PvaCO2 gap increased the sensitivity and specificity with AUROC of 0.93 and accuracy of 91% in predicting mortality. Ospina-Tascón et al. [14] reported that a persistently high PvaCO2 gap could independently predict adverse outcomes and lactate changes regardless of other oxygen-derived variables. The PvaCO2 gap is a simple and attractive goal in resuscitation but it is a physiologically complex tool and should be studied with oxygen changes as it may be normal despite tissue hypoperfusion if associated with high blood flows preventing CO2 accumulation. Also the PvaCO2 gap may increase without tissue hypoperfusion in aerobic and anaerobic conditions due to the Haldane effect as the relation between the CO2 partial pressure and the CO2 content is affected by O2 saturation, pH differences, and hemoglobin changes [40].As CO2 production does not exceed O2 production during aerobic metabolism, correcting the PvaCO2 gap by using the ratio of PvaCO2 to the arteriovenous oxygen content difference (CavO2) may detect patients with a risk of anaerobic metabolism [14, 40, 41]. Mekontso-Dessap et al. [15] reported that a PvaCO2 to CavO2 ratio of 1.4 was superior to PvaCO2 in predicting hyperlactatemia and also reported the agreement between PvaCO2/CavO2 ratio and blood lactate levels. Our study showed a difference in the PvaCO2/CavO2 ratio combined with lactate clearance in the survivors compared to the nonsurvivors who develop increased ratio and lactate elevation after 6 hours of resuscitation. Our results showed that PvaCO2/CavO2 ratio was a predictor of mortality in the multivariate regression analysis. The PvaCO2/CavO2 ratio cutoff of 1.4 had an AUROC of 0.793 in differentiating mortality. Our ROC analysis to determine possible cutoffs for lactate, PvaCO2, and PvaCO2/CavO2 to predict mortality showed that blood lactate had a superior performance differentiating mortality. However, combining the cutoffs for lactate and PvaCO2 or PvaCO2/CavO2 provided higher specificity (98% and 93.2%, respectively) than blood lactate levels alone (75.3%) with higher accuracy. Our results were consistent with Ospina-Tascón et al.’s [42] study that described lactate and PvaCO2/CavO2 ratio as independent predictors of mortality after 6 hours of resuscitation. Interestingly, Ospina-Tascón et al. [42] reported that, after getting the MAP ≥65 mmHg and ScvO2% ≥ 65% in most enrolled patients, 48% of the studied patients had a PvaCO2/CavO2 ratio ˃1 and 62% of patients had a blood lactate ˃2 mmol/L. Ospina-Tascón et al. [42] reported that patients with combined high lactate and PvaCO2/CavO2 ratio at T6 had the worst outcomes. Patients with normalized lactate level and PvaCO2/CavO2 ratio had the best outcomes, while patients with normalized lactate but still high PvaCO2/CavO2 ratio had similar unfavorable outcomes to those with high lactate levels with normalized PvaCO2/CavO2 ratio.We used SOFA score to assess the clinical severity of the studied patients and the degree of multisystem dysfunction after resuscitation. The SOFA score has been previously used in different critically ill patients and is linked to mortality and outcomes [43–45]. Our results revealed that the nonsurvivors had higher initial SOFA and increasing scores trend after 48 hours of admission compared to the survivors. Also, the increasing trend of SOFA score was an independent predictor of mortality after resuscitation. Mesquida et al. [46] used SOFA scoring and reported increased SOFA trend and PvaCO2/CavO2 ratio in nonsurvivors after resuscitation. Ospina-Tascón et al. [42] divided the septic shock patients into four groups based on the blood lactate and PvaCO2/CavO2 ratio and reported the highest scores in the group with combined lactate ≥2 mmol/L and PvaCO2/CavO2 ratio ˃1 and the lowest scores in patients with low lactate ˂2 mmol/L and PvaCO2/CavO2 ratio ˂1.Finally, our data showed that septic shock patients who were unlikely to survive persistently had worsening lactate levels with high PvaCO2 and PvaCO2/CavO2 ratios, despite resuscitation. Increased oxygen extraction was associated with increased lactate clearance and improving markers of anaerobic metabolism. Adding PvaCO2 gap and PvaCO2/CavO2 ratio to lactate measurements can increase the accuracy of mortality prediction.


## 5. Conclusion

Combining the carbon dioxide gap and arteriovenous oxygen difference with lactate clearance during the early hours of resuscitation of adult patients with septic shock helps to predict hospital mortality more accurately.



---

*Source: 6918940-2021-09-26.xml*